(Q41414669)
Statements
Selepressin, a novel selective vasopressin V1A agonist, is an effective substitute for norepinephrine in a phase IIa randomized, placebo-controlled trial in septic shock patients (English)
James A Russell
Anne Louise Kjølbye
Håkan Olsson
Allan Blemings
Peder Carl
Pierre-Francois Laterre
Lars Grundemar
15 August 2017
1 reference
1 reference
1 reference